Ensemble Modeling of the Likely Public Health Impact of a Pre-Erythrocytic Malaria Vaccine
Background:
The RTS,S malaria vaccine may soon be licensed. Models of impact of such vaccines have mainly considered deployment via the World Health Organization's Expanded Programme on Immunization (EPI) in areas of stable endemic transmission of Plasmodium falciparum, and have been calibrated for such settings. Their applicability to low transmission settings is unclear. Evaluations of the efficiency of different deployment strategies in diverse settings should consider uncertainties in model structure.
Methods and Findings:
An ensemble of 14 individual-based stochastic simulation models of P. falciparum dynamics, with differing assumptions about immune decay, transmission heterogeneity, and treatment access, was constructed. After fitting to an extensive library of field data, each model was used to predict the likely health benefits of RTS,S deployment, via EPI (with or without catch-up vaccinations), supplementary vaccination of school-age children, or mass vaccination every 5 y. Settings with seasonally varying transmission, with overall pre-intervention entomological inoculation rates (EIRs) of two, 11, and 20 infectious bites per person per annum, were considered. Predicted benefits of EPI vaccination programs over the simulated 14-y time horizon were dependent on duration of protection. Nevertheless, EPI strategies (with an initial catch-up phase) averted the most deaths per dose at the higher EIRs, although model uncertainty increased with EIR. At two infectious bites per person per annum, mass vaccination strategies substantially reduced transmission, leading to much greater health effects per dose, even at modest coverage.
Conclusions:
In higher transmission settings, EPI strategies will be most efficient, but vaccination additional to the EPI in targeted low transmission settings, even at modest coverage, might be more efficient than national-level vaccination of infants. The feasibility and economics of mass vaccination, and the circumstances under which vaccination will avert epidemics, remain unclear. The approach of using an ensemble of models provides more secure conclusions than a single-model approach, and suggests greater confidence in predictions of health effects for lower transmission settings than for higher ones.
: Please see later in the article for the Editors' Summary
Vyšlo v časopise:
Ensemble Modeling of the Likely Public Health Impact of a Pre-Erythrocytic Malaria Vaccine. PLoS Med 9(1): e32767. doi:10.1371/journal.pmed.1001157
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1001157
Souhrn
Background:
The RTS,S malaria vaccine may soon be licensed. Models of impact of such vaccines have mainly considered deployment via the World Health Organization's Expanded Programme on Immunization (EPI) in areas of stable endemic transmission of Plasmodium falciparum, and have been calibrated for such settings. Their applicability to low transmission settings is unclear. Evaluations of the efficiency of different deployment strategies in diverse settings should consider uncertainties in model structure.
Methods and Findings:
An ensemble of 14 individual-based stochastic simulation models of P. falciparum dynamics, with differing assumptions about immune decay, transmission heterogeneity, and treatment access, was constructed. After fitting to an extensive library of field data, each model was used to predict the likely health benefits of RTS,S deployment, via EPI (with or without catch-up vaccinations), supplementary vaccination of school-age children, or mass vaccination every 5 y. Settings with seasonally varying transmission, with overall pre-intervention entomological inoculation rates (EIRs) of two, 11, and 20 infectious bites per person per annum, were considered. Predicted benefits of EPI vaccination programs over the simulated 14-y time horizon were dependent on duration of protection. Nevertheless, EPI strategies (with an initial catch-up phase) averted the most deaths per dose at the higher EIRs, although model uncertainty increased with EIR. At two infectious bites per person per annum, mass vaccination strategies substantially reduced transmission, leading to much greater health effects per dose, even at modest coverage.
Conclusions:
In higher transmission settings, EPI strategies will be most efficient, but vaccination additional to the EPI in targeted low transmission settings, even at modest coverage, might be more efficient than national-level vaccination of infants. The feasibility and economics of mass vaccination, and the circumstances under which vaccination will avert epidemics, remain unclear. The approach of using an ensemble of models provides more secure conclusions than a single-model approach, and suggests greater confidence in predictions of health effects for lower transmission settings than for higher ones.
: Please see later in the article for the Editors' Summary
Zdroje
1. London School of Hygiene and Tropical Medicine Public Health Forum 1992 Malaria: waiting for the vaccine London Wiley
2. BejonPLusinguJOlotuALeachALievensM 2008 Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age. N Engl J Med 359 2521 2532
3. AbdullaSOberholzerRJumaOKubhojaSMacheraF 2008 Safety and immunogenicity of RTS,S/AS02D malaria vaccine in infants. N Engl J Med 359 2533 2544
4. BallouWR 2009 The development of the RTS,S malaria vaccine candidate: challenges and lessons. Parasite Immunol 31 492 500
5. SmithTKilleenGFMaireNRossAMolineauxL 2006 Mathematical modeling of the impact of malaria vaccines on the clinical epidemiology and natural history of Plasmodium falciparum malaria: overview. Am J Trop Med Hyg 75 1 10
6. PennyMAMaireNStuderASchapiraASmithTA 2008 What should vaccine developers ask? Simulation of the effectiveness of malaria vaccines. PLoS ONE 3 e3193 doi:10.1371/journal.pone.0003193
7. MacdonaldG 1957 The epidemiology and control of malaria London Oxford University Press
8. Le MenachATakalaSMcKenzieFEPerisseAHarrisA 2007 An elaborated feeding cycle model for reductions in vectorial capacity of night-biting mosquitoes by insecticide-treated nets. Malar J 6 10
9. SaulAGravesPMKayBH 1990 A cyclical feeding model for pathogen transmission and its application to determine vectorial capacity from vector infection-rates. J Appl Ecol 27 123 133
10. ChitnisNSmithTSteketeeR 2008 A mathematical model for the dynamics of malaria in mosquitoes feeding on a heterogeneous host population. J Biol Dyn 2 259 285
11. GreenwoodB 2008 Progress in malaria control in endemic areas. Travel Med Infect Dis 6 173 176
12. HaySIRogersDJToomerJFSnowR 2000 Annual Plasmodium falciparum entomological inoculation rates (EIR) across Africa: literature survey, Internet access and review. Trans R Soc Trop Med Hyg 94 113 127
13. WoolhouseMEDyeCEtardJFSmithTCharlwoodJD 1997 Heterogeneities in the transmission of infectious agents: implications for the design of control programs. Proc Natl Acad Sci U S A 94 338 342
14. BejonPWilliamsTNLiljanderANoorAMWambuaJ 2010 Stable and unstable malaria hotspots in longitudinal cohort studies in Kenya. PLoS Med 7 e1000304 doi:10.1371/journal.pmed.1000304
15. RossASmithT 2010 Interpreting malaria age-prevalence and incidence curves: a simulation study of the effects of different types of heterogeneity. Malar J 9 132
16. TrapeJFLefebvre-ZanteELegrosFNdiayeGBouganaliH 1992 Vector density gradients and the epidemiology of urban malaria in Dakar, Senegal. Am J Trop Med Hyg 47 181 189
17. DongusSNyikaDKannadyKMtasiwaDMshindaH 2009 Urban agriculture and Anopheles habitats in Dar es Salaam, Tanzania. Geospat Health 3 189 210
18. BelizarioVYSaulABustosMDLansangMAPasayCJ 1997 Field epidemiological studies on malaria in a low endemic area in the Philippines. Acta Trop 63 241 256
19. Gamage-MendisACCarterRMendisCDe ZoysaAPHerathPR 1991 Clustering of malaria infections within an endemic population: risk of malaria associated with the type of housing construction. Am J Trop Med Hyg 45 77 85
20. TractonMSKalnayE 1993 Operational ensemble prediction at the National Meteorological Center: practical aspects. Weather Forecast 8 378 398
21. GrasslyNMorganMWalkerNGarnettGStaneckiK 2004 Uncertainty in estimates of HIV/AIDS: the estimation and application of plausibility bounds. Sex Transm Infect 80 31 38
22. JohnsonLFAlkemaLDorringtonRE 2010 A Bayesian approach to uncertainty analysis of sexually transmitted infection models. Sex Transm Infect 86 169 174
23. HalloranMEFergusonNMEubankSLonginiIMJrCummingsDA 2008 Modeling targeted layered containment of an influenza pandemic in the United States. Proc Natl Acad Sci U S A 105 4639 4644
24. BrownTSalomonJAAlkemaLRafteryAEGouwsE 2008 Progress and challenges in modelling country-level HIV/AIDS epidemics: the UNAIDS Estimation and Projection Package 2007. Sex Transm Infect 84 Suppl 1 i5 i10
25. DietzK 1988 Mathematical models for transmission and control of malaria. WernsdorferWHMc GregorI Malaria, principles and practice of malariology Edinburgh Churchill Livingstone 1091 1133
26. KoellaJCAntiaR 2003 Epidemiological models for the spread of anti-malarial resistance. Malar J 2 3
27. RossAPennyMMaireNStuderACarneiroI 2008 Modelling the impact of intermittent preventive treatment in infants. PLoS ONE 3 e2661 doi:10.1371/journal.pone.0002661
28. MaireNShillcuttSWalkerDGTediosiFSmithT 2011 Cost effectiveness of the introduction of a pre-erythrocytic malaria vaccine into the Expanded Program on Immunization in sub-Saharan Africa: analysis of uncertainties using a stochastic individual-based simulation model of Plasmodium falciparum malaria. Value Health 1028 1038
29. The MalERA Consultative Group on Modeling 2010 A research agenda for malaria eradication: modeling. PLoS Med 8 e1000403 doi:10.1371/journal.pmed.1000403
30. MaireNSmithTRossAOwusu-AgyeiSDietzK 2006 A model for natural immunity to asexual blood stages of Plasmodium falciparum malaria in endemic areas. Am J Trop Med Hyg 75 19 31
31. RossAMaireNMolineauxLSmithT 2006 An epidemiologic model of severe morbidity and mortality caused by Plasmodium falciparum. Am J Trop Med Hyg 75 63 73
32. SmithTRossAMaireNRogierCTrapeJF 2006 An epidemiologic model of the incidence of acute illness in Plasmodium falciparum malaria. Am J Trop Med Hyg 75 56 62
33. SmithTMaireNDietzKKilleenGFVounatsouP 2006 Relationship between the entomologic inoculation rate and the force of infection for Plasmodium falciparum malaria. Am J Trop Med Hyg 75 11 18
34. RossAKilleenGFSmithT 2006 Relationships of host infectivity to mosquitoes and asexual parasite density in Plasmodium falciparum. Am J Trop Med Hyg 75 Suppl 2 32 37
35. TediosiFMaireNSmithTHuttonGUtzingerJ 2006 An approach to model the costs and effects of case management of Plasmodium falciparum malaria in sub-saharan Africa. Am J Trop Med Hyg 75 90 103
36. MaireNAponteJJRossAThompsonRAlonsoP 2006 Modeling a field trial of the RTS,S/AS02A malaria vaccine. Am J Trop Med Hyg 75 104 110
37. SmithTMaireNRossAPennyMChitnisN 2008 Towards a comprehensive simulation model of malaria epidemiology and control. Parasitology 135 1507 1516
38. MaireNTediosiFRossASmithT 2006 Predictions of the epidemiologic impact of introducing a pre-erythrocytic vaccine into the expanded program on immunization in sub-Saharan Africa. Am J Trop Med Hyg 75 111 118
39. WhiteMTGriffinJTDrakeleyCJGhaniAC 2010 Heterogeneity in malaria exposure and vaccine response: implications for the interpretation of vaccine efficacy trials. Malar J 9 82
40. OlotuALusinguJLeachALievensMVekemansJ 2011 Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5–17 months in Kenya and Tanzania: a randomised controlled trial. Lancet Infect Dis 11 102 109
41. SacarlalJAidePAponteJJRenomMLeachA 2009 Long-term safety and efficacy of the RTS,S/AS02A malaria vaccine in Mozambican children. J Infect Dis 200 329 336
42. WoolhouseME 1998 Patterns in parasite epidemiology: The peak shift. Parasitol Today 14 428 434
43. SmithTHiiJGentonBMullerIBoothM 2001 Associations of peak shifts in age-prevalence for human malarias with bed net coverage. Trans R Soc Trop Med Hyg 95 1 6
44. MoorthyVSBallouWR 2009 Immunological mechanisms underlying protection mediated by RTS,S: a review of the available data. Malar J 8 312
45. AidePDobanoCSacarlalJAponteJJMandomandoI 2011 Four year immunogenicity of the RTS,S/AS02(A) malaria vaccine in Mozambican children during a phase IIb trial. Vaccine 29 6059 6067
46. AlonsoPLSacarlalJAponteJJLeachAMaceteE 2005 Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial. Lancet 366 2012 2018
47. AsanteKPAbdullaSAgnandjiSLyimoJVekemansJ 2011 Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial. Lancet Infect Dis 11 741 749
48. CarneiroIRoca-FeltrerAGriffinJTSmithLTannerM 2010 Age-patterns of malaria vary with severity, transmission intensity and seasonality in sub-Saharan Africa: a systematic review and pooled analysis. PLoS ONE 5 e8988 doi:10.1371/journal.pone.0008988
49. GriffinJTHollingsworthTDOkellLCChurcherTSWhiteM 2010 Reducing Plasmodium falciparum malaria transmission in Africa: a model-based evaluation of intervention strategies. PLoS Med 7 e1000324 doi:10.1371/journal.pmed.1000324
50. ChandramohanDWebsterJSmithLAwineTOwusu-AgyeiS 2007 Is the Expanded Programme on Immunisation the most appropriate delivery system for intermittent preventive treatment of malaria in West Africa? Trop Med Int Health 12 743 750
51. KeiserJUtzingerJDe CastroMCSmithTATannerM 2004 Urbanization in sub-Saharan Africa and implication for malaria control. Am J Trop Med Hyg 71 118 127
52. HaySIGuerraCAGethingPWPatilAPTatemAJ 2009 A world malaria map: Plasmodium falciparum endemicity in 2007. PLoS Med 6 e1000048 doi:10.1371/journal.pmed.1000048
53. BinkaFIndomeFSmithT 1998 Impact of spatial distribution of permethrin-impregnated bed nets on child mortality in rural northern Ghana. Am J Trop Med Hyg 59 80 85
54. HawleyWAPhillips-HowardPter KuileFTerlouwDJVululeJM 2003 Community-wide effects of permethrin-treated bed nets on child mortality and malaria morbidiy in western Kenya. Am J Trop Med Hyg 68 Suppl 4 121 127
55. HowardSCOmumboJNevillCSomeESDonnellyCA 2000 Evidence for a mass community effect of insecticide-treated bednets on the incidence of malaria on the Kenyan coast. Trans R Soc Trop Med Hyg 94 357 360
56. GosoniuLVounatsouPTamiANathanRGrundmannH 2008 Spatial effects of mosquito bednets on child mortality. BMC Public Health 8 356
57. AndersonRAKnolsBKoellaJC 2000 Plasmodium falciparum sporozoites increase feeding-associated mortality of their mosquito hosts Anopheles gambiae s.l. Parasitology 120 329 333
58. TrapeJFRogierC 1996 Combating malaria morbidity and mortality by reducing transmission. Parasitol Today 12 236 240
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2012 Číslo 1
- Statinová intolerance
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Metamizol v liečbe pooperačnej bolesti u detí do 6 rokov veku
- Co dělat při intoleranci statinů?
Najčítanejšie v tomto čísle
- Ensemble Modeling of the Likely Public Health Impact of a Pre-Erythrocytic Malaria Vaccine
- Adult Mortality Attributable to Preventable Risk Factors for Non-Communicable Diseases and Injuries in Japan: A Comparative Risk Assessment
- What Will It Take to Eliminate Pediatric HIV? Reaching WHO Target Rates of Mother-to-Child HIV Transmission in Zimbabwe: A Model-Based Analysis
- Challenging Medical Ghostwriting in US Courts